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Abstract 
This project has two aims. First it aims to investigate the role of Ntg2 in the mismatch repair 
system (MMR) in yeast cells. Ntg2 is an A/P-glycosylase which is part of the base excision 
repair (BER) system in S. cerevisiae. It has been found that Ntg2 binds MLH1 which is a 
major component of MMR in eukaryotes. It has also been shown that over expression of 
Ntg2 in WT yeast cells leads to higher mutation frequency in a canavanine resistance assay, 
as if the MMR system did not function properly [Gellon et al, 2002]. By use of the same 
assay we tested the mutation frequency of WT, EXO1- and MLH1- in the BY4741 yeast strain 
with and with out over expression of Ntg2 . We were unable to replicate the results from 
Gellon et al, 2002. We saw no significant difference between the normal WT-cell and WT-
cells over expressing Ntg2. Neither saw we difference in the EXO1- -cells. The MLH1- -cells 
over expressing Ntg2 did not present a mutation frequency high enough to be detected, 
which we must regard as an error in the method. To verify the results we sequenced the 
Ntg2 insert and found no mutations. The contradiction between Gellon et al.’s results and 
ours is most properly due to the difference in cell-strains. 
Second, the project aims to examine the inserts of the plasmids used in an earlier work. This 
earlier study concluded that human EXO1 could not complement MMR in a ScEXO1 
deficient yeast strain. By sequencing the inserts of the plasmids used in this earlier study, we 
wished to prove that the results of the complementation study was not due to mutations in 
the inserts of the plasmids used. The WT-hEXO1 insert and the hEXO1(T439M)-insert where 
both as expected, and mutations in the inserts cannot be the cause for the complementation 
results. The hEXO1(L410R)-insert contained an insertion mutation of 65 bases not found in 
WT-hEXO1. This mutation caused the protein to turn into a nonsense-protein. The protein is 
abolished and therefore cannot complement the ScMMR. However, it properly wouldn’t 
complement without the insertion mutation, as the WT doesn’t complement.  
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Abstrakt (Abstract in Danish)  
Nærværende projekt har til formål at undersøge to problemstillinger. Det første formål er at 
undersøge Ntg2’s effekt på MMR systemet i S. cerevisiae. Ntg2 er en A/P-glykosylase, som 
er en del af BER systemet i S. cerevisiae.  Det er fundet at Ntg2 binder til MLH1, som er en 
komponent af MMR i eukaryoter. Det er endvidere vist at overudtryk af Ntg2 i en WT 
gærcelle, giver en forøget mutationsfrekvens [Gellon et al, 2002]. Ved brug af et canavanin 
resistens assay, har vi undersøgt mutationsfrekvensen af en WT, EXO1- og MLH1- stamme  
med og uden overudtryk af Ntg2. Det var ikke muligt for os at reproducere resultaterne fra 
Gellon et al. 2002. Vi observerede ingen signifikant forskel på mutationsfrekvensen mellem 
de normale WT celler og WT celler med overudtryk af Ntg2. Vi observerede heller ingen 
forskel på mutationsfrekvensen hos EXO1- celler. MLH1- cellerne med overudtryk af Ntg2 
viste en ekstrem lav mutationsfrekvens, dette resultat må anses for at være usandsynligt. For 
at verificere resultaterne sekventerede vi Ntg2 insertet og fandt at der ingen mutationer var i 
genet. Forskellen mellem Gellon et al.’s resultater og vores, skyldes sandsynligvis de 
forskellige celleliner anvendt i forsøgene.  
Andet formål var at undersøge inserts i plasmider anvendt i et tidligere studie. Dette studie 
konkluderede at hEXO1 ikke kunne komplementere ScMMR i en EXO1 defekt gærstamme. 
Ved sekventering af plasmiderne fra det tidligere studie, ønskede vi at undersøge om  
resultaterne fra det tidligere studie skyldtes mutationer i inserts’ne. WT-hEXO1 og 
hEXO1(T439M) inserts’ne var begge fri for mutationer og sådanne kan derfor ikke være 
årsag til komplementation resultaterne. hEXO1(L410R) insertet viste sig at indeholde en 
indsættelses mutation på 65 baser. Denne mutation resulterer i at proteinet omdannes til et 
nonsens-protein. Derved er proteinet ikke funktionelt og kan ikke komplementere MMR 
systemet i gær. Proteinet ville dog formentlig heller ikke komplementere uden mutationen, da 
WT hEXO1 ikke kan komplementere.  
 
3 
 
The effect of Ntg2 on MMR 
 
1 Introduction 
The following chapter will motivate the project and define the problems this project aims to 
solve.  
 
The project has two aims. First, it aims to investigate the influence of a component of the 
base excision repair system (BER) on the mismatch repair system (MMR) in Saccharomyces 
cerevisiae (S. cerevisiae). Both systems are DNA repair systems. BER takes care of missing 
bases and damaged bases, which have been changed by oxidising agents or other 
mutagens in the cell. MMR is a post-replicative system that corrects mismatched bases 
which the proofreading system has missed. 
Second, we want to examine the plasmids used in an earlier work, which concluded that 
human EXO1 could not complement the MMR system in a ScEXO1 deficient yeast strain. 
This latter aim will be discussed in the end of this chapter, first the repair systems of the cell 
will be discussed. 
 
If changes in DNA are not repaired the cells will accumulate mutations that can lead to 
cancer. Some cancers are initiated by repair systems that are mutated and can not repair the 
DNA properly. Such cancers are Hereditary non-polyposis colon cancer (HNPCC) and 
Xeroderma pigmentosum (XP). XP is a skin cancer and is caused by deficiencies in the 
nucleotide excision repair system (NER) that takes care of mutations caused by UV-light 
[Griffiths et al. 2000]. Mutations that might lead to cancer have also been found in some 
proteins of the BER system [Bai et al., 2005; Colebatch et al., 2006; Kim et al., 2003; Hung et 
al., 2005]. 
 
Known cases of HNPCC are caused by mutations in genes that translates to proteins in the 
MMR system. These patients are born with a mutation in one of the two copies of a MMR 
gene. They live normal lives as the gene on the other allele is functioning. This allele, 
however might get a mutation in the same gene and the cell has no functioning copy of the 
MMR protein. If the hit protein is a major component of MMR system, the system might be 
almost completely abolished. A non-functioning MMR system will lead to other mutations in 
the genome and proto-oncogenes may be hit with the development of cancer as a possible 
consequence. [ Kunkell & Erie, 2005; Liberti,  2003] 
 
4 
 
 The effect of Ntg2 on MMR  
 
 5
A hypothesis currently discussed is the mutator phenotype hypothesis, which proposes the 
need of a mutator mutation in the cells, in order for them to develop into cancer cells [Loeb et 
al., 2003]. But an obvious mutator mutation, which generates new mutations like one in a 
major MMR-gene is not found in all cancers, why the hypothesis cannot be proved yet. 
 
The repair systems and their regulating are of major significance to the fidelity of the DNA 
and to the risk of generating mutations. Different repair enzymes from different systems may 
bind to the same mutation in the DNA, even if the mutation is caused by a certain mutagen. 
As a consequence of that it has been proposed that the different repair systems in the cells 
regulate each other. Results from other studies might support this hypothesis. The human 
MytY homolog (hMYH), which is a BER enzyme that corrects 8-oxodG (GO) mutations, has 
been found to bind hMSH6 and to be regulated by the hMSH2/hMSH6 heterodimer from the 
MMR system [Gu et al., 2002]. Msh2 in yeast binds Rad10 from the NER system and seems 
to facilitate the repair of mutations caused by UV-light [Bertrand et al. 1998]. It has been 
found that the Ntg2 protein, that is part of BER in yeast binds MLH1 which is an important 
MMR protein [Gellon et al., 2002]. No finished theory has been formed yet about the 
regulation of repair systems, but it is a very important field in the landscape of DNA repair 
system studies. 
 
In this project we decided to use the latter study as our hypothesis and try to repeat the 
results found by Gellon et al. 2002. By investigating the effect of the Ntg2 protein on the 
fidelity of the repair by the MMR system, we might be able to come closer to describing the 
relationship between these two DNA repair systems in the cell.   
 
We have transformed three S. cerevisiae strains with the Ntg2 gene in a plasmid send to us 
from Serge Boiteux and used a canavanine resistance assay to measure the mutation 
frequency in three S. cerevisiae strains.  
 
Gellon et al. 2002 also used the canavanine resistance assay along with two other assays in 
order to measure the mutation frequency caused by dysfunction in the MMR system in the 
DNA. The hypothesis proposed by Gellon et al. is that the mutation frequency will rise if Ntg2 
binds and prevents MLH1 from participating in the DNA repair of the MMR system. Their 
results showed a higher mutation frequency in cells overexpressing Ntg2 and they 
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concluded, that this result might be due to Ntg2 abolishing the MMR system by binding 
hMLH1. 
 
This project will investigate the effect of overexpression of Ntg2 on the mutation frequency in 
a WT, EXO1- and MLH1- yeast strain different. The problem can be expressed as follows:  
 
What effect does overexpression of Ntg2 have on the mutation frequency in a WT, EXO1- 
and MLH1- yeast strain? 
 
The EXO1- strain exhibits a low mutation frequency and the MLH1- a very high mutation 
frequency. If Ntg2 does really disrupt the MMR system through MLH1, we should be able to 
detect a higher mutation frequency in the EXO1- cells and WT cells, when Ntg2 is 
overexpressed. The MLH1- cells must be expected to have the same high mutation 
frequency, when Ntg2 is overexpressed, as Ntg2 has nothing to bind to without MLH1. As we 
discuss the results from our experiments, we will have to consider if our results supports the 
hypothesis about MMR-abolishing by Ntg2.  
 
In a previous project, in which we have conducted some of the work, it was found that the 
human MMR protein hEXO1 did not complement a MMR system in yeast with no working 
EXO1. Other studies have shown a complementation [Qiu et al., 1999].To examine our 
results, we decided to sequence the inserts of the plasmids used in the previous work. The  
inserts was WT hEXO1, hEXO1(L410R) and hEXO1(T439M). The two mutant forms of 
hEXO1 are found in HNPCC-patients. The problem to investigate is as follows:  
 
Do the inserts of the plasmids used in the previous complementation experiment contain 
unexpected mutations? 
 
We will sequence the insets and align them with the expected proteins.  
 
In order to give the reader a better understanding of the mechanisms by which cells repair 
their DNA, the following chapters will discuss the MMR and BER repair systems. A very short 
chapter will then review interaction between these two repair systems and right after this the 
experimental method is explained. In chapter 6 the results is presented and the following 
chapters discuss the results. 
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2 Mismatch Repair 
This chapter reviews the organisation and function of the mismatch repair system (MMR).  
 
Different repair systems have been characterized; MMR, BER, NER and double stranded 
break (DSB) repair. These different repair systems operate individually, but have many 
overlapping functions. The MMR system is a post-replicative system, and its primary role is 
the maintenance of DNA fidelity upon replication.  
 
It is important for the cell to repair damaged DNA to avoid accumulation of mutations. The 
MMR system reverse errors in the newly synthesized DNA strand, which are missed by the 
polymerase proofreading. The system thereby lowers the mutation frequency [Kunkel & Erie, 
2005] The MMR system corrects base-base mispairing and insertion/deletion loops (IDLs) 
and protects the cells from microsatellite instability (MSI). The MMR system is essential to all 
organisms, but the different mechanisms and functions are best understood in Escherichia 
Coli (E. coli), therefore a short description of the MMR system in E. coli follows.  
2.1 Mismatch Repair in E. Coli 
In order to correct a DNA-base in the newly synthesized strand, the MMR system must be 
able to discriminate between the two DNA strands. In E. coli this mechanism is conducted by 
methylation of the template strand a short period of time after replication. Dam methylase, 
methylates DNA at N6 position of all adenines within (5’)GATC sequences, and makes it 
possible for the MMR proteins to discriminate between the two strands and correct the 
mismatches up to 1000bp, from the nearest hemimethylated GATC sequence. [Nelson & 
Cox, 2005] 
 
The initial phase of MMR is dependent on three proteins, MutS, MutL and MutH, each with a 
unique function. MMR is initiated when MutS recognise a mismatch in the newly synthesized 
DNA strand and binds to it. MutS is a homodimer of the product of the MutS gene. It contains 
ATPase activity, which is required for MMR.  [Kunkel & Erie, 2005; Marti et al., 2002]. The 
binding of MutS to the mismatch increases the affinity for MutL, and together they form a 
complex and a DNA loop is formed. Like MutS, MutL is an ATPase and also exists as a 
homodimer. MutL couple mismatch recognition to the downstream MMR events [Buermeyer 
et al., 1999].  
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Figure 1: MMR in E. coli [Liberti, 2003] 
 
The complex of MutS and MutL, makes it possible for MutH to be activated and to make the 
nick in the unmethylated strand, that will encircle the mismatch. MutH is an endonuclease 
and can discriminate between the newly synthesized strand and the template strand, by 
mean of hemimethylated GATC sites. It introduces a nick in the nascent unmethylated strand 
opposite a hemimethylated GATC site. MutH binds to MutL and to the DNA strand. [Nelson & 
Cox, 2005]. At the nicked site MutL helps to load DNA helicase II (UvrD) on the DNA and 
UvrD unwinds the dsDNA from the nick and forward, past the mismatch. As indicated above 
MMR is bidirectional, meaning that the nick can be introduced either 3’ or 5’ to the mismatch.  
 
In the next phase of MMR one of four DNA-specific exonucleases will remove the error-
containing DNA strand depending on the polarity of the reaction. ExoI and ExoX degrade 
3’→5’ and ExoVIII and RecJ 5’→3’. The exonucleases degrade the DNA from the nick to the 
mismatch. This leaves a single-stranded gap, which will be stabilized by single-strand-
binding protein (SSB). The DNA is resynthesized by DNA polymerase III and the final nick is 
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closed by DNA ligase. The MMR pathway is ended by methylation of the newly synthesized 
strand. The MMR in E. coli is illustrated in figure 1.  
2.2 Mismatch Repair in Eukaryotes 
The current picture of the MMR in eukaryotic cells resembles the one of E. coli to a great 
extend, but with two important differences, the strand discrimination and the fact that MutS 
and MutL functional homologues are heterodimeric [Jun et al., 2006]. Compared to the MMR 
system in E. coli, the eukaryotic MMR system is much more complex, and the entire process 
has so far, not been completely clarified, but eukaryotic cells have proteins that are 
functionally and structurally homologs to the ones found in E. coli. As seen in table 1, the 
eukaryotic cells have six homologs to MutS and MutL, but no homologs for MutH has been 
found [Kunkel & Erie, 2005; Buermeyer et al., 1999]. The three MutS homologs make up two 
heterodimers, MutSα (MSH2⋅MSH6) and MutSβ (MSH2⋅MSH3). MutSα is primarily 
responsible for the repair of base-base mismatches and small IDLs, and MutSβ is mainly 
responsible for repair of IDL mismatches containing up to 16 extra nucleotides in one strand 
[Kunkel & Erie, 2005; Buermeyer et al., 1999].  
 
E. Coli S. cerevisiae H. sapiens Function 
MutS Msh2⋅Msh6 
 
Msh2⋅Msh3 
MutSα (hMSH2⋅hMSH6) 
 
MutSβ (hMSH2⋅hMSH3) 
Recognizes base-base and 
small IDL mismatches. 
Recognizes IDLs ≥ 2 bases. 
MutL MLH1⋅Pms1 
MLH1⋅Mlh2 
 
MLH1⋅Mlh3 
MutLα (hMLH1⋅hPms2) 
MutLβ (hMLH1⋅hPms1) 
 
MutLγ (hMLH1⋅hMlh3) 
Matchmaker. 
Unknown function of human 
heterodimer. 
Suppresses some IDL 
mutagenesis. 
MutH None None Endonuclease that nicks the 
unmethylated strand in E. coli 
Table 1: Some of the MMR proteins identified in E. coli, S. cerevisiae and H. Sapiens. 
[Kunkel & Erie, 2005; Buermeyer et al., 1999] 
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When the MutS homolog complexes bind to the DNA mismatch, the repair is initiated, see 
figure 2 for the MMR in human cells. MutSα or MutSβ binds to the mismatch and MutLα 
binds in the presence of ATP.  
 
There exists four homologs of MutL in eukaryotes, see table 1. MutLα plays a major role in 
mutation avoidance, as it is involved in repairing mismatches. In yeast MutLβ and MutLγ 
participate in repairing a subset of IDLs. In humans MutLγ is also found to participate in 
repairing IDLs. MutLγ is also involved in recombination [Kunkel & Erie, 2005]. The function of 
MutLβ in humans is not known. 
 
As mentioned no homologues for MutH is known in eukaryotes, and therefore, no 
endonuclease to introduce the nick in the newly synthesized DNA strand is found. It is still 
unknown how the MMR system discriminates between the template strand and the newly 
synthesized strand, as the template strand doesn’t get methylated, but it may be either 
mediated by the replication accessory factor PCNA or it simply could be achieved by a 
recognition of gaps, nicks or 3’ free ends that are present during replication. [Fleck & 
Nielsen, 2004]  
 3'
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Figure 2: MMR in human cells. [Liberti, 2003] 
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The DNA MMR in eukaryotes occur bidirectional and therefore both 3’→5’ and 5’→3’ 
exonuclease activity is required. It is known that eukaryotes use EXO1 for mismatch 
correction and 5’→3’ activity have been found for EXO1. When the mismatch have been 
identified EXO1 remove nucleotides one by one until it reaches the mismatch. hEXO1 has 
binding sites for hMSH2, hMSH3 and hMLH1 and can function in in-vitro MMR. No other 
exonucleases are known in human MMR, but the proofreading exonucleases of DNA Pol δ 
and ε have been suggested. [Kunkel & Erie, 2005] When the strand is excised beyond the 
mismatch the strand is resynthesized by Pol δ, in the presence of PCNA and RPA. Sealing 
the remaining nick by a yet not identified ligase will complete the MMR. [Jun et al., 2006] 
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3 Base Excision Repair  
This chapter will review the mechanisms of BER, in order to introduce Ntg2, which is the 
component of the BER system used in this study.  
 
BER is a DNA glycosylase repair pathway found in both prokaryotic and eukaryotic cells. The 
function of the system is to remove damaged bases from the DNA. These bases can arise in 
several ways, they can be methylated, oxidated or deaminated.  
 
Ntg2 used in this study is an example of a glycosylase in BER that recognises oxidized 
bases in S. cerevisiae, therefore we focus on the repair of oxidized bases in this chapter.  
Figure 3 shows examples of oxidized DNA bases, which specific DNA glycosylases can 
recognise and excise.  
 
    
 
Figure 3: Examples of oxidized DNA-bases. [Girard and Boiteux, 1997] 
 
The oxidized DNA bases can be both mutagenic and cytotoxic for the cells, why they have to 
be removed. For comparison the mutations repaired by the MMR system are primarily 
mutagenic and not cytotoxic. The cytotoxic effect is partly due to the fact, that some 
damaged bases can block DNA replication [Alseth et al., 1999], therefore BER must be a 
pre-replication repair-system compared to the post-replication repair system MMR.  
 
The BER pathways are initiated by DNA glycosylases that excise the damage base (or in 
some cases the base opposite) from the DNA. All glycosylases are small monomeric proteins 
that do not require cofactors for their activity of excising damaged or mispaired bases 
[Krokan et al., 1997]. A/P-glycosylases can scan the DNA, find the distortion and remove the 
damaged base from the DNA-strand, by cleaving the base-sugar binding [Griffiths et al. 
12 
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2000]. After the bases have been excised an empty place in the DNA is formed, this is called 
an apurinic/apyrimidinic (AP) site. [Boiteux and Guillet, 2004] 
3.1 Oxidation glycosylases in E. coli  
In E. coli oxidized bases are excised by three different glycosylases: Formamidopyrimidine 
DNA glycosylase (Fpg) also called mutM, Nth also called endonuclease III and Nei also 
called endonuclease VIII. Fpg excises the oxidized purines called 8-OxoG and faPy and Nth 
and Nei excises the oxidized pyrimidines called thymine-glycol and 5-hydroxycytosine, se 
bases on figure 3.[Alseth et al., 1999]  
3.2 Base excision repair in S. cerevisiae 
In S. cerevisiae Nth has two homologues Ntg1 and Ntg2, which has somewhat the same 
function and Fpg which has two homologs Ogg1 and Ogg2 [Krokan et al., 1997]. The Ntg2 
protein, resembles Ntg1 and Ogg1, but unlike Ntg1, Ntg2 contains a [4Fe-4S] cluster found in 
most endonuclease III like proteins [Girard & Boiteux, 1997]. Both Ntg1 and Ntg2 contain a 
conserved hairpin-helix-hairpin motif thought to be involved in DNA-binding [Meadows et al., 
2003]. The Ntg2 gene localizes to the chromosome XV in S. cerevisiae and the protein 
contains 380 amino acids [Girard & Boiteux, 1997]. The Ntg2 protein is found exclusively in 
the nucleus while Ntg1 localizes to the mitochondria and the nucleus [Alseth et al., 1999]. 
Ntg2 is also continuously expressed in the cells while Ntg1-levels seem to change according 
to the levels of substrates [Alseth et al., 1999].  
 
In E.coli it is possible to group the glycosylases in pyrimidine repair proteins and purine 
repair proteins. The picture is not as clear in S. cerevisiae. Ntg1 and Ntg2 removes thymine 
glycol and faPy with same efficiency, but 5-hydroxycytocine is removed efficiently only by 
Ntg2 [Alseth et al., 1999].  Ntg1 and Ntg2 are both bifunctional in that respect that both 
glycosylases are A/P lyases as well. They catalyze strand cleavage on the 3’ side of the AP 
site with similar efficiency and none of them have preferences as to the base opposite the AP 
site [Meadows et al., 2003]. 
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Figure 4: “Base excision repair of AP sites and “honorary AP sites” in Saccharomyces 
cerevisiae” [Boiteux and Guillet, 2004].  AP sites can occur as a consequence of the action of 
a glycoylase, but they can also just occur spontaneous in the DNA. In both cases BER 
proteins take action. Ntg1, Ntg2 and Ogg1 are all bifunctional regarding their activity. They 
have glycosylase activity and endonuclease activity. Therefore the repair of the AP site can 
be initiated by either Ntg1, Ntg2 or Ogg1 or by the AP endonucleases Apn1 or Apn2. The 
endonucleatic activity differs in placing the nick. Apn1 and Apn2 introduces a nick on the side 
of the AP site toward the 5’ end of the strand and Ntg1, Ntg2 and Ogg1 introduces a nick on 
the side closest to the 3’ end of the strand. A nick closest to the 5’ end is not difficult for the 
cell to repair. Polymerase ε can attach directly to the nicked strand and synthesise a new 
patch of DNA. If needed an endonuclease removes the DNA overhang and a ligase ligates 
the single strand break.  
When the nick is introduced closest to the 3’ end of the strand polymerase can not bind to 
the nick. Polymerisation can not be initiated without a 3’-OH. Two pathways have been 
proposed to accommodate this problem. First Apn1 or Apn2 are also 3’ phosphodiesteraser 
and can cut the DNA backbone in order to present the wanted 3’-OH. Polymerase ε and 
ligase can then finish the repair. Second a DNA helicase have been proposed to open the 
DNA and make room for an endonuclease to get rid of the overhang. This would give a 
polymerase the opportunity to synthesise a new DNA bit, and ligase can finish of the repair. 
 
In this project we focus on the repair of oxidized bases, as it is in this pathway Ntg2 
participates. However when the damaged base is removed by a glycosylase specific for the 
oxidizing damage, the AP site prompts a set of repair pathways common for all AP sites. This 
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pathway is shown for S. cerevisiae on figure 4. After the damaged base is removed BER 
endonucleases introduce a nick in the strand next to the AP site. Some glycosylases are also 
endonucleases and conducts the first two steps of BER, in other cases the endonuclease is 
recruited and conducts its function.  
 
As shown on figure 4 introducing of a nick in the DNA open a set possibilities for the repair of 
the DNA. Regardless of the different proteins and functions involved in the repair a 
polymerase is recruited to synthesize a new patch of DNA and a ligase finishes the repair by 
sealing the nick. For explanation of figure 4, se text below figure. The finishing of the BER 
repair is similar to the finishing in MMR. 
3.3 Base Excision Repair in Humans 
In humans, an Nth-homolog hNTH1 has been found, and the human hMMH/hOGG1 has 
been found to be homologues to Fpg and OGG1. [Glassner et al., 1998] Three homologues 
of Nei has also been found in humans, they are called Nei-like 1-3 (NEIL1, NEIL2 and 
NEIL3). [Hazra et al. 2006] No homologues of Ntg2 have been found yet. 
 
The human BER repair pathway resembles the one in yeast, but other proteins are involved. 
In figure 5 pathway I and III is initiated by bifunctional glycolases homologues to Ogg1 in S. 
cerevisiae and to nth in E.coli. Hereby this model shows two possibilities in the case of 
bifunctional glycosylases and the task of creating a 3’-OH for the polymerase to bind. Like in 
yeast the choice between monofunctional (pathway II on figure 5) and bifunctional 
glycosylases is decisive for the proteins in play in the next step of the pathway.  
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Figure 5: “A model for APE and PNK-dependent BER pathways in mammalian cells” 
[Reprinted from Ref. 57 in Hazra et al. 2006]:  Three BER sub-pathways (I, II, and III) defined 
by the type and reaction mechanism of DNA glycosylases are shown. In pathway II 
monofunctional glycosylases (M) generate AP sites which are cleaved by APE1 to leave a 5′ 
deoxyribosephosphate and a 3´-OH for Pol β to use. The deoxyribosephosphate is removed 
by Pol β producing a single-nucleotide gap necessary for nucleotide addition. In pathway I 
NTH1 and OGG1 carry out β elimination and APE1 removes the 3′ dRP and a single 
nucleotide gap with a 3′-OH is generated. In pathway III NEILs are the initial glycosylases. A 
3′ phosphate end is generated which is then removed by PNK and a single-nucleotide gap 
with a 3´-OH end is created for Pol β and the ligase to repair.  
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4 Interaction between Mismatch Repair and Base 
Excision Repair 
It has not yet been clarified by which mechanisms different repair systems in cells are 
regulated. As more than one system is often able to repair the same DNA damage or 
mutation, the repair systems have been proposed to regulate each other to some extend.  
 
It has been found that the BER glycosylase hMYH that excises adenine (A) opposite of 8-
OxoG in humans interacts with hMSH6 of hMutSα. hMSH6 has been reported to bind and 
regulate the activity of hMYH. hMYH does not have the ability to differ between the two 
strands. Therefore it might just remove the template A opposite an 8-OxoG on the new 
strand, and other repair proteins will replace the damaged G and a polymerase will put in a 
new base opposite G. This will lead to an A-T ? G-C transition. In the study it was proposed 
that hMutSα might be able to make sure that hMYH only excises adenines from the newly 
replicated strand. [Gu et al., 2002] In this respect it is interesting to note, that hMYH is one of 
the BER proteins that is suspected to be mutated in some cancers [Colebatch et al., 2006; 
Kanter-Smoler et al., 2006], and that hMutSα is mutated in many cases of HNPCC 
[Thompson et al., 2004]  
  
Other BER proteins have been reported to bind (and possible regulate or be regulated by) 
MMR proteins. The MED1 glycosylase in humans and the Ntg2 in yeast have both been 
found to bind hMLH1 and MLH1 respectively [Fan & Wilson, 2005] and [Gellon et al., 2002]. 
Whether the Ntg2-MLH1 binding resembles the hMYH-hMutSα binding, when it comes to the 
reason for the binding, will be discussed later.    
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5 Method 
This section will describe the methods used in our project. The methods are the mutation 
frequency assay and sequencing analysis. Furthermore the section will describe the 
fluctuation test, because the calculations of the results from the mutation frequency assay 
are based on this test. 
5.1 Mutation Frequency Assay 
In this assay the aim is to investigate the effect of Ntg2 in excess on the fidelity of the MMR 
system. If Ntg2 overexpression inhibits MMR, we will detect it through an elevated mutation 
frequency.  
 
In order to overexpress Ntg2 in the cells, we transformed our yeast strains with the pYX213 
plasmid containing the Ntg2 gene, see appendix 12.1 for transformation protocol. If Ntg2 is 
expressed from the plasmid and from the nuclear DNA of the yeast cells it should be in 
excess in the cells. The gene on the plasmid is regulated by a promoter that needs galactose 
for initiating the transcription, therefore the plasmid gene should only be expressed in the 
presence of galactose. However the galactose-promoter might be leaky, which means that it 
might allow some transcription of the Ntg2 gene regardless of galactose. Never the less we 
conducted the experiments in media with galactose (SG-media) and without galactose (SD-
media), to be able to detect which mutation frequency, the cells containing the plasmid 
without overexpressing Ntg2 would present. To be able to compare the mutation frequency 
of the strains containing the plasmid with WT cells, we have conducted experiments with 
untransformed cells as well.  
 
Besides containing the Ntg2 gene the pYX213 plasmid also contains a gene for uracil, 
without which the cells will die. The yeast strains used does not contain uracil on their DNA. 
Therefore only cells containing the plasmid can grow in media without uracil. For all strains 
transformed and untransformed we confirmed, that the cells were vital. This was done for all 
strains by plating them on full media plates without canavanine. The colony number on these 
plates was used in the calculation of the mutation frequency, se the paragraph on fluctuation 
test. 
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In the mutation frequency assay we use CAN1 gene as a marker gene. Canavanine is an 
analogue to arginine and cause cell death by terminating the translation. Arginine is an 
amino acid. Mutations in the can1+ gene make the cells resistant to canavanine. Can1 
encodes an arginine permease which when absent or out of function, prevents cells from 
taking up canavanine, therefore cells grown in media without arginine but containing 
canavanine will incorporate canavanine into proteins and die. If the arginine permease 
(CAN1), which is responsible for the uptake of canavanine, is inactivated, as a result of one 
or more spontaneous mutations, the cell cannot take up canavanine and become resistant to 
canavanine, (WTCAN(sensitive) → MutCAN (resistant)). In our experiments, the yeast cells are spread 
on plates containing canavanine and one colony represent one mutation. The arginine 
permease makes the spontaneous mutations measurable. 
 
The protocol for the mutation frequency assay is presented in appendix 12.1. All of the 
experiments were carried out independently and at least three times.  
5.1.1 The Fluctuation Test 
The standard procedure for determining the spontaneous mutation rate has since 1943 been 
to grow cells in tubes in complete medium. The number of cells is determined by plating 
dilutions of the cells and the mutation frequency is determined by plating the cells on a 
selective medium. The fluctuation test is based on the variance in mutant number.  
 
The aim of the Mutation Frequency Assay is to determine the total number of mutations 
during the experiment, and therefore it is necessary to consider that mutations will arise 
random in time. For instance, cells can divide early in the experiment or possibly very late on 
the selective plates, which will give enormously different results, as the early mutations will 
give a much higher mutation frequency than if the mutations takes place late in the period. 
Because of this, it is convenient to use The Fluctuation Test to overcome this problem. In this 
project we use The Method of the Median, as described by Von Borstel in 1978 (Von Borstel, 
1978), which is a useful method when most or all cells contain mutations. In this method the 
highest and the lowest mutation frequency number is discarded. If you have an even number 
of growth tubes the average, of the middle two values is calculated and if you have an 
uneven number of growth tubes, the median number is chosen in order to estimate the 
frequency. [Von Borstel, 1978]  
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In all of our experiments we used an uneven number of tubes, five at each experiment. 
Although we have an uneven number, we have discarded the highest and the lowest value 
and taken the average number of the three remaining numbers and not the median number. 
This method was used in order to be able to compare our results with the results from our 
previous work, where this method was used. It should be noted that this method, calculating 
the average value, does not influence the results, as the median number is close to the one 
we calculate. This value is designated r0. From the r0 value, it is possible to determine the 
mean number of mutants per cell culture (corrective factor) r0/m, which can be read in the 
table (preliminary estimation of m from the median value of ra) in Von Borstel, 1978. Then the 
average mutation frequency m, can be estimated by:  
 
m = r0/(r0/m) 
 
In order to estimate the standard deviation, the value of r0/m were read in the table for all the 
three middle values and the average of these were calculated and used to determine the 
average mutation frequency, m, presented in the next chapter.   
5.2 The Original Project 
Originally the aim of this project was to use the canavanine resistance assay to determine 
the frequency of mutations arising as a consequence of the HNPCC mutations L410R (found 
in HNPCC patients) and T439M (found in HNPCC patients and in controls) in hEXO1. 
Besides the HNPCC mutations the intention was to make site-directed mutagenesis in order 
to create four additional mutations, P757L, S504A, F506A and F507A all in hEXO1. The 
mutation frequency of the HNPCC mutants were to be compared with cells expressing the 
WT hEXO1, and the result would be expected to show that the HNPCC mutations would lead 
to genetic instability compared with the WT. In the experiment we transform S. cerevisiae 
EXO1- strains with plasmids, expressing WT hEXO1, hEXO1 L410R and T439M.  
 
A necessary condition for the experiment in order to determine the mutation frequency of the 
HNPCC mutations is, that hEXO1 is able to complement the activity of ScEXO1 in yeast 
MMR, in respect to mutation prevention. Earlier research (Qiu et al., 1999) has shown that 
hEXO1 can complement its homolog in S. cerevisiae, in respect to different functions, 
including mutation prevention to a certain degree. Qui et al. used a cycloheximide assay to 
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determine the mutation frequency and the results are shown in table 2, together with our own 
results.  
 
Genotype Mutation frequency (x10-6) Relative rate 
WTA 0,0022 ± 0,05 1 
WTBB 1,26±0,11 1,00±0,08 
EXO1-A 0,0621 ± 0,81 29 
EXO1-BB 6,46±1,56 5,11±1,30 
EXO1-/hEXO1A 0,0112 ± 0,21 5,1 
EXO1-/hEXO1BB 0,0697±0,59 5,52±0,65  
EXO1-/ScEXO1A 0,0028 ± 0,09 1,3 
Table 2: Mutation frequencies from complementation experiments. The genotypes marked 
with an A are results carried out by Qiu et al., and the genotypes marked with a B are results 
from our experiments. The relative rate is calculated for each experiment, A and B.  
 
As seen in table 2, hEXO1A is to a certain extent capable of complementing ScEXO1A in the 
cycloheximide assay. hEXO1 in EXO1- cells has the ability to reduce the relative mutation 
frequency from 29 to 5,1 but the cells transformed with hEXO1 still has an enhanced 
mutation frequency compared to cells transformed with ScEXO1.   
 
Many experiments were executed but we not able to obtain the same results as Qiu et al. In 
our study hEXO1 could not complement ScEXO1 in yeast MMR. The results of one of the 
experiments are shown in table 2, together with the results from Qiu et al. The experiment 
was conducted several times under different conditions, e.g. ±uracil, but the results were the 
same. Therefore we concluded that in the canavanine assay hEXO1 could not complement 
ScEXO1. These results caused the aim of the project to change, and we decided to stop the 
mutagenesis experiments, which we had performed several times without success.  
 
In the experiment performed by Qiu et al. they used a strain and vectors different from the 
ones in our study, see information on strains in section 5.4. These differences could be one 
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reason, why we were not able to obtain the same result. They also used cycloheximide 
resistance as marker while we used canavanine resistance.  
 
Never the less we decided to sequence the different inserts of the plasmids containing 
HNPCC hEXO1 and WT hEXO1, in order to determine if one or more mutations in the inserts 
could be the reason, why we were not able to show the complementation. The results of the 
sequencing analysis are shown in chapter 6.  
5.3 Sequencing Analysis 
Besides sequencing the three inserts in the pYES2-plasmid: WT hEXO1, hEXO1(L410R) 
and hEXO1(T439M), we decided to sequence the Ntg2 insert of the pYX213-plasmid from 
Serge Boiteux, see next section for plasmid information. The sequencing of Ntg2 was done 
in order determine, that the sequence was as expected so that no mutation would influence 
the results.  
 
The plasmids for sequencing were purified and concentrated by the QIAprep Spin Miniprep 
Kit. The inserts were sequenced by the method used in LJR laboratories at Roskilde 
University, Denmark, se the protocol in appendix 12.1.  
 
For every insert we had to run the sequencing procedure several times, because duplication 
of DNA in a PCR machine can only be done in pieces  of max 600 bases as one primer only 
can sequence a limited piece of DNA. The method is to duplicate the piece of the insert in a 
PCR machine, then fell it and rinse it to get a higher concentration. A sequencing-machine 
found the sequence of the duplicated DNA piece, and we checked if the DNA-bit had the 
expected DNA code. For every DNA-piece we used a primer to start the PCR. Several 
primers were used to sequence the inserts in both plasmids. The primers used to sequence 
Ntg2 in pYX213, we designed from the sequence of Ntg2, and the primers used to sequence 
the three different inserts in pYES2 were primers from LJR’s laboratory. For the primer 
sequences view appendix 12.4.  
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5.4 Yeast Strain and Plasmid Information 
During the experiments different yeast strains and plasmids were used.  
5.4.1 Strains used in the Experiments:  
S. cerevisiae, BY4741 (WT strain: Y0), MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0. 
S. cerevisiae, BY4741 (EXO1- strain: Y01809), MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0. 
S. cerevisiae, BY4741 (MLH1- strain: Y00750), MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0. 
5.4.2 Plasmids used in the Experiments:  
pYX213-NTG2, galactose-inducible expression of native NTG2, AmpR; URA3.  
pYES2-hEXO1, hEXO1b insert with two polymorphisms at 2538 bp, AmpR (CarbR). 
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6 Results  
This chapter is divided in two parts, first the results from the mutation frequency assay will be 
reviewed and second the results from the sequencing analysis, of the insert in pYX-213 and 
pYES2, will be reviewed.  
6.1 Results from the Mutation Frequency Assay 
The results from the mutation frequency assay is divided in three, the results from strains 
without Ntg2, the results from the cells transformed with Ntg2 grown in media and on plates 
containing galactose, and at last cells transformed with Ntg2 grown in media and on plates 
without galactose. As mentioned Ntg2 has a galactose inducible promotor, and therefore 
Ntg2 will be turned on in the presence of galactose and turned off when galactose is not 
present.  
6.1.1 Mutation Frequencies of Untransformed Yeast Cells 
Before transformation with Ntg2, multiple experiments were carried out to determine the 
relationship between the mutation frequency of WT, EXO1- and MLH1-. This was partly done 
to confirm that deletion of EXO1 increases the mutation frequency compared to the WT, and 
that deletion of MLH1 increases the mutation frequency compared to the EXO1- cells. 
Furthermore the experiment can indicate if the CAN1 gene, can be used as a measure for 
the MMR activity. The results of this experiment are reviewed in table 3.
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Genotype Mutations Frequencies (x10-6) Relative Rate 
WTA 1,40±0,14 1±0,10 
WTBB 0,85±0,2 1±0,23 
EXO1-A 4,18±0,63 2,97±0,54 
EXO1-BB 3,68±0,64 4,32±1,28 
MLH1-A 15,97±3,45 11,37±2,70 
MLH1-BB 16,38±6,79 19,21±9,26 
Table 3: Mutation frequencies from two independent experiments1 A and B with 
untransformed yeast cells. 
 
The results in table 3 illustrate data from two independent experiments2. The experiments 
have been carried out in the exact same way, and the results show the same tendency. The 
mutation frequency is lowest in the wild type cells, increased approximately 3-4-fold in the 
EXO1 deficient cells, and approximately increased 10-20-fold in MLH1 deficient cells, 
compared to the wild type cells. As MLH1 is one of the essential proteins in the MMR 
system, it is not surprising that the mutation frequency from the MLH1- cells is much higher 
than both the wild type and the EXO1-. The high mutation frequency is a result of, an inactive 
MMR system. Furthermore the mutation frequency of the EXO1 deficient cells can be 
distinguished from the wild type by having a 3-4-fold higher frequency. This may reflect that 
in EXO1- cells the MMR system is not completely inactivated, but only partly functioning. 
Moreover the results from table 3, may indicate that the canavanine resistance assay can be 
used to illustrate the MMR activity. 
 
After the initial experiments with the untransformed cells, the mutation frequency assay with 
the Ntg2 transformed cells were carried out. 
                                                 
1 More experiments were performed but as the results showed the same as the ones we present, these are not shown. 
2 More experiments were performed but as the results showed the same as the ones we present, these are not shown. 
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6.1.2 Mutation Frequencies of Ntg2 Transformed Yeast Cells Grown in Minimal 
SG-media 
The results from two independent experiments3, with cells grown in the presence of 
galactose to express Ntg2 is presented in table 4. The experiments were performed in the 
exact same way and under the same conditions 
 
Genotype Mutations Frequencies (x10-6) Relative Rate 
WT/Ntg2C 0,62±0,03 1,00±0,05 
WT/Ntg2D 0,89±0,02 1,00±0,02 
EXO1-/Ntg2C 3,81±0,14 6,12±0,39 
EXO1-/Ntg2D 3,26±0,81 3,66±0,91 
MLH1-/Ntg2C 0,10±0,00 0,16±0,009 
MLH1-/Ntg2D 0,00±0,00 0,00±0,00 
Table 4: Mutation frequencies from two independent experiments C and D with Ntg2 
transformed yeast cells grown with galactose. 
 
The result show that the EXO1-/Ntg2 cells grown in galactose have a 3,5-6 fold increased 
mutation frequency compared to the WT/Ntg2, and that MLH1-/Ntg2 grown in galactose has 
a extremely low mutation frequency (close to 0), lower than the WT/Ntg2 frequency.  
                                                 
3 More experiments were performed but as the results showed the same as the ones we present, these are not shown. 
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6.1.3 Mutation Frequencies of Ntg2 Transformed Yeast Cells Grown in Minimal 
SD-media 
The results from two independent experiments4, with cells grown in the absence of 
galactose, is presented in table 5. The experiments were performed in the exact same way 
and under the same conditions. 
 
Genotype Mutations Frequencies (x10-6) Relative Rate 
WT/Ntg2E 0,92±0,057 1,00±0,06 
WT/Ntg2F 1,00±0,10 1,00±0,11 
EXO1-/Ntg2E 5,83±0,49 6,36±0,66 
EXO1-/Ntg2F 7,24±3,16 7,25±3,23 
MLH1-/Ntg2E 0,00±0,00 0,00±0,00 
MLH1-/Ntg2F 0,23±0,14 0,23±0,14 
Table 5: Mutation frequencies from two independent experiments E and F with Ntg2 
transformed yeast cells grown without galactose. 
 
The result from table 5 show that the EXO1-/Ntg2 cells grown without galactose have a 6-7 
fold increased mutation frequency compared to the WT/Ntg2, and that MLH1-/Ntg2 cells 
grown without galactose have a extremely low mutation frequency (close to 0), lower than 
the WT/Ntg2 frequency. 
                                                 
4 More experiments were performed but as the results showed the same as the ones we present, these are not shown. 
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6.2 Summary of the Results from the Mutation Frequency Assay 
Average Mutation Frequency Number in Yeast
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Figure 6: Average mutation frequency number in yeast.  
 
As seen in figure 6, the result from the untransformed cells equals the results from the Ntg2 
transformed cells, except for the MLH1-/Ntg2 results. Because of the peculiar result of the 
MLH1-/Ntg2, new transformations were made and new mutation frequency assay 
experiments performed. The result were the same, on all of the selective plates no colonies 
or only very few were observed. Because of this result we tried to spread a greater amount 
but with no result, still few or no colonies were observed.  
 
As described, the experiments were performed in two different media, SD and SG. We 
expected to see different mutation frequencies, as the Ntg2 would be expressed in the 
presence of galactose, and therefore we expected that the mutation frequency would be 
greater for the cells grown in SG-media than for the cells grown in SD-media. As seen on 
figure 6, no significant differences are observed. 
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6.3 Sequencing of Ntg2-inserts in pYX213 
 
In order to validate the results from the experiments with Ntg2p we sequenced the Ntg2-
insert. The Ntg2 gene in the pYX213 from Serge Boiteux is a synthetic construct clone of 
Ntg2 from S. cerevisiae, which we assume does not differ from the real gene in any way. We 
have sequenced the insert and translated it, to present it in the amino acid sequence. To 
confirm that the inserts was in fact Ntg2 from S. cerevisiae, we have “blasted” the sequences 
on http://www.ncbi.nlm.nih.gov/BLAST/.  
 
A 1  MREESRSRKRKHIPVDIEEVEVRSKYFKKNERTVELVKENKINKDLQNYGGVNIDWIKAL  60 
B  249533  MREESRSRKRKHIPVDIEEVEVRSKYFKKNERTVELVKENKINKDLQNYGGVNIDWIKAL  249354 
 
A  61   KPIEYFEWIESRTCDDPRTWGRPITKEEMINDSGAKVPESFLPIYNRVRLMRSKVKTPVD  120 
B  249353   KPIEYFEWIESRTCDDPRTWGRPITKEEMINDSGAKVPESFLPIYNRVRLMRSKVKTPVD  249174 
 
A  121      AMGCSMIPVLVSNKCGIPSEKVDPKNFRLQFLIGTMLSAQTRDERMAQAALNITEYCLNT  180 
B  249173   AMGCSMIPVLVSNKCGIPSEKVDPKNFRLQFLIGTMLSAQTRDERMAQAALNITEYCLNT  248994 
 
A  181      LKIAEGITLDGLLKIDEPVLANLIRCVSFYTRKANFIKRTAQLLVDNFDSDIPYDIEGIL  240 
B  248993   LKIAEGITLDGLLKIDEPVLANLIRCVSFYTRKANFIKRTAQLLVDNFDSDIPYDIEGIL  248814 
 
A  241      SLPGVGPKMGYLTLQKGWGLIAGICVDVHVHRLCKMWNWVDPIKCKTAEHTRKELQVWLP  300 
B  248813   SLPGVGPKMGYLTLQKGWGLIAGICVDVHVHRLCKMWNWVDPIKCKTAEHTRKELQVWLP  248634 
 
A  301      HSLWYEINTVLVGFGQLICMARGKRCDLCLANDVCNARNEKLIESSKFHQLEDKEDIEKV  360     
B  248633   HSLWYEINTVLVGFGQLICMARGKRCDLCLANDVCNARNEKLIESSKFHQLEDKEDIEKV  248454 
 
A  361      YSHWLDTVTNGITTERHKKK  380                 
B  248453   YSHWLDTVTNGITTERHKKK  248394 
 
Figure 7: Amino acid sequence of A: Ntg2-insert in pYX213 aligned with B: the Ntg2 gene on 
Chromosome XV in S. cerevisiae. The numbering counts the amino acid number of the insert 
and the chromosome.    
 
As seen on figure 7 the insert corresponds completely with the Ntg2 protein from 
chromosome XV in S. cerevisiae. In the DNA-sequence however a polymorphism in the 
insert appears on amino acid number 152 and DNA-base number 456. A CTT triplet has 
been changed to CTC, see appendix 12.3 for the DNA-sequence of Ntg2. This change has 
no consequence for the protein as both triplets translate to Leucine. The amino acid is 
marked with purple on figure 7. The sequence analyses show that the Ntg2-insert in pYX213 
has the correct sequence. 
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6.4 Sequencing of hEXO1-inserts in pYES2 
The hEXO1, we work with is an Exonuclease 1, isoform b from Homo sapiens. In this copy of 
the gene, there are two polymorphisms compared to the real hEXO1 gene. The 
polymorphisms are located on amino acid 354 and 589. We have sequenced the three 
inserts and translated them to present them in their amino acid sequences. In order to 
confirm that the inserts was in fact Exonuclease 1, we have “blasted” the sequences on 
http://www.ncbi.nlm.nih.gov/BLAST/.  
 
A  301  YEDDVDPETLSYAGQYVDDSIALQIALGNKDINTFEQIDDYNPDTAMPAHSRSHSWDDKT  360 
B  301  YEDDVDPETLSYAGQYVDDSIALQIALGNKDINTFEQIDDYNPDTAMPAHSRSRSWDDKT  360 
C  301  YEDDVDPETLSYAGQYVDDSIALQIALGNKDINTFEQIDDYNPDTAMPAHSRSRSWDDKT  360 
D  301  YEDDVDPETLSYAGQYVDDSIALQIALGNKDINTFEQIDDYNPDTAMPAHSRSRSWDDKT  360 
 
A  361  CQKSANVSSIWHRNYSPRPESGTVSDAPQLKENPSTVGVERVISTKGLNLPRKSSIVKRP  420 
B  361  CQKSANVSSIWHRNYSPRPESGTVSDAPQLKENPSTVGVERVISTKGLNLPRKSSIVKRP  420 
C  361  CQKSANVSSIWHRNYSPRPESGTVSDAPQLKENPSTVGVERVISTKGLNLPRKSSIVKRP  420 
D  361  CQKSANVSSIWHRNYSPRPESGTVSDAPQLKENPSTVGVERVISTKGLNRPRKSSTKGLN  420 
 
A  421  RSAELSEDDLLSQYSLSFTKKTKKNSSEGNKSLSFSEVFVPDLVNGPTNKKSVSTPPRTR  480 
B  421  RSAELSEDDLLSQYSLSFTKKTKKNSSEGNKSLSFSEVFVPDLVNGPTNKKSVSTPPRTR  480 
C  421  RSAELSEDDLLSQYSLSFMKKTKKNSSEGNKSLSFSEVFVPDLVNGPTNKKSVSTPPRTR  480 
D  421  RPRKSSLKG  429 
 
A  481  NKFATFLQRKNEESGAVVVPGTRSRFFCSSDSTDCVSNKVSIQPLDETAVTDKENNLHES  540 
B  481  NKFATFLQRKNEESGAVVVPGTRSRFFCSSDSTDCVSNKVSIQPLDETAVTDKENNLHES  540 
C  481  NKFATFLQRKNEESGAVVVPGTRSRFFCSSDSTDCVSNKVSIQPLDETAVTDKENNLHES  540 
 
A  541  EYGDQEGKRLVDTDVARNSSDDIPNNHIPGDHIPDKATVFTDEESYSFESSKFTRTISPP  600 
B  541  EYGDQEGKRLVDTDVARNSSDDIPNNHIPGDHIPDKATVFTDEESYSFKSSKFTRTISPP  600 
C  541  EYGDQEGKRLVDTDVARNSSDDIPNNHIPGDHIPDKATVFTDEESYSFKSSKFTRTISPP  600 
 
Figure 8: Piece of amino acid sequence of A: Homo sapiens Exonuclease 1, isoform b 
compared with B: WT-hEXO1-insert in pYES2, C: hEXO1(T439M)-insert in pYES2 and D: 
hEXO1(L410R)-insert in pYES2. The numbering counts the amino acids of the proteins. 
Polymorphisms at amino acid 354 and 589 are marked with purple. The L410R and T439M -
mutations are marked with yellow and green. The translated insertion-mutation in L410R is 
marked with red.  
6.4.1 Wild type hEXO1 
On figure 8 a part of the inserts are compared with the isoform b of human Exonuclease 1 
(hEXO1b) found during blasting (A on figure 8). See appendix 12.2 to view the complete 
amino acid sequence. The figure shows that the wildtype-insert (B on figure 8) correspond 
with EXO1b in all amino acids but the two polymorphisms at amino acid 354 and 589 marked 
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with purple on figure 8. The sequence analyses show that the wild type hEXO1-insert is not 
mutated. 
6.4.2 hEXo1(T439M) 
The hEXo1(T439M)-insert (C on figure 8) also correspond with the hEXO1b protein in all 
amino acids, but the two polymorphisms and the threonine on amino acid 439 that becomes 
methionine marked with green on figure 8. In the insert-gene, the mutation is a single 
nucleotide mismatch where the codon ACG becomes ATG.  
The sequence analyses show that the hEXO1(T439M)-insert is right. 
6.4.3 hEXo1(L410R) 
The hEXo1(L410R)-insert (D on figure 8) looks exactly like the two other inserts in the first 
part of the protein. It contains the polymorphi on amino acid 354 and it has a mutation on 
amino acid 410 as expected. On amino acid 410 a mismatch leads to the incorporation of 
argenine in stead of leucine marked with yellow on figure 8. Also in this case it is a single 
nucleotide mismatch that gives rise to the amino acid switch, the codon CTC is in hEXo1- 
(L410R) CGC, marked with yellow on figure 9.  
 
However the hEXo1(L410R)-insert contains a 65 basepair (bp) long sequence (insertion-
mutation) that is not found in hEXO1b or in either of the other inserts. Figure 9 shows a piece 
of the hEXO1(L410R)-insert sequenced with the 65 bp insertion-mutation in red text. The 
sequence starts on amino acid 416 (figure 8) right after the patch where the L410R-primer 
have been used (se the primer-sequence with blue text on figure 9). The new sequence is 
marked with red on figure 8 and 9. We have sequenced this patch of the insert 5 times with 
same result.   
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1171 AAG GAA AAT CCA AGT ACT GTG GGA GTG GAA  
1201 CGA GTG ATT AGT ACT AAA GGG TTA AAT CGC   
1231 CCA AGG AAA TCA TCC ACT AAA GGG TTA AAT 
1261 CGC CCA AGG AAA TCA TCC CTA AAG GGT TAA 
1291 ATC GCC CAA GGA AAT CAT CCA TTG TGA AAA  
1321 GAC CAA GAA GTG CAG AGC TGT CAG AAG ATG  
1351 ACC TGT TGA GTC AGT ATT CTC TTT CAT TTA  
1381 CGA AGA AGA CCA AGA AAA ATA GCT CTG AAG  
1411 GCA ATA AAT CAT TGA GCT TTT CTG AAG TGT  
1441 TTG TGC CTG ACC TGG TAA ATG GAC CTA CTA 
Figure 9: DNA-sequence of a piece of the hEXO1(L410R)-insert in pYES2. The numbering 
counts the DNA-bases of the insert. The primer used to introduce the L410R mutation is 
marked with blue. The mismatch leading to the L410R-mutation is marked with yellow. The 
65 bp long insertion-mutation in the gene is in red text and two stopcodons are marked with 
grey.  
 
In the 65 bp insert a stopcodon is created at base number 1288-1290 as the 15’th triplet of 
the insertion mutation and the amino acid sequence stops right after amino acid 429 on 
figure 8. Had a stopcodon not stopped the protein at this spot another stopcodon at base 
number 1423-1425 would have stopped it as a consequence of the frameshift caused by the 
insertion-mutation. The insertion-mutation starts right after a triplet in the old readingframe, 
but as it is 65 bp long it cannot divide into an even number of triplets, why the frame of the 
gene is shifted in the following sequence. On figure 9 the two stopcodons are marked with 
gray.  
The sequence analyses show that the hEXO1(410)-insert is not correct, the mutation will 
have to be introduced again in a WT hEXO1 with no insertion-mutation. 
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7 Discussion 
In the following sections we will discuss all of our results from the mutation frequency assay 
and the sequencing analysis, starting with the mutation frequency assay. 
7.1 Discussion of the Results from the Mutation Frequency Assay 
Figure 10 below illustrates the results obtained from canavanine resistance assays. The 
results are partly from our own experiments and partly from experiments carried out by 
Gellon et al. 2002. The results from number 1-9 in figure 10 are our own and number 10-13 
is the results by Gellon et al. In the following our results will be discussed and compared first, 
second the results of Gellon et al. will be discussed. 
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Figure 10: Average mutation frequency number in yeast cells.  
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As described in section 6.1.1 the results from the untransformed strains shows the expected 
mutation frequencies, MLH1- as 10-20 times more mutagenic than the wild type cells, and 
EXO1- only around 4 times as mutagenic. These results are in consistency with earlier 
results that showed this tendency [Johnson et al., 1998]. Furthermore the results showed 
that the canavanine resistance assay may be useable in order to measure the mutation 
frequency in yeast cells, however this will be discussed. The aim of this study has been to 
compare these mutation frequencies with the frequency from cells overexpressing the Ntg2-
gene.  
 
Surprisingly the mutation frequency of the MLH1-/Ntg2 was very close to cero, even though 
we tried to change the experimental conditions. We had expected to get a high mutation 
frequency because of the inactive MMR system in MLH1- cells. Even though we did the 
experiments with the MLH1-/Ntg2 cells several times and with the same outcome we cannot 
put great emphasis on our results. It is not likely that the lack of colonies on the plates, 
symbolising the mutation frequency in the MLH1-/Ntg2 cells, is actually caused by a very low 
mutation frequency. It may be due to a low vitality of the MLH1-/Ntg2 cells in an –arginine, -
uracil environment compared to the same cells growing in full media.  
 
If we hypothetic were to believe the results, the low mutation frequency would be difficult to 
explain, as it seems that Ntg2 have the ability to protect the cells against the mutations 
caused by the lack of MLH1. This would mean that in the MLH1-/Ntg2 cells the MMR system 
corrects the DNA mismatches more efficient than in the WT/Ntg2 cells. This seems odd 
though as MLH1 and Ntg2 do not resemble one another at all. What might happen in stead is 
that the BER system takes over the function of the MMR system. This is an excessive 
hypothesis however, more experiments would have to be conducted to prove or more likely 
disprove it. 
 
Other unforeseen results from the mutation frequency assay is observed. There is no 
difference regarding the mutation frequencies between untransformed WT & EXO1- cells and 
WT/Ntg2 & EXO1-/Ntg2, as presented by Gellon et al. This divergence may be caused by the 
difference in cell lines. There might naturally be an elevated amount of MLH1 in our cell line 
compared to the one used in Gellon et al. 2002. In that case the binding of MLH1 by Ntg2 
may not influence the MMR system because the MLH1 in excess is still available and no 
difference in mutation frequency will appear. Other explanations to this observation could be 
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lack of expression of the Ntg2 gene from the Plasmid. If Ntg2 were not expressed in the cells 
no difference between the untransformed cells and the WT/Ntg2 & EXO1-/Ntg2 would appear 
in regards of the mutation frequency.  
 
As described Ntg2 has a galactose inducible promotor and therefore the results are carried 
out in media containing galactose and in media lacking galactose. A leaky promoter may 
cause the lack of difference between the mutation frequency, in cells expressing Ntg2 and 
not expressing Ntg2. Still, even if the promotor is leaky the Ntg2 gene should not be 
transcribed in the same extend as in the presence of galactose. We had hoped to observe 
that the cells grown in galactose containing media had a higher mutation frequency 
compared with the cells grown in galactose free media. In that case mutation frequencies in 
cells overexpressing Ntg2, could be compared with cells expressing a natural amount of 
Ntg2. The lack of difference can also be due to the MLH1 expression in the cells discussed 
above or to problems regarding the plasmid or Ntg2-gene expression. 
 
Gellon et al. set out to investigate the interaction between Ntg2p and MLH1p in S. cerevisiae, 
therefore the mutation frequency of EXO1- is not examined in their study. As seen on figure 
10 Gellon et al. use a strain with a vector without insert (‘vector only’ on figure 10) as the 
reference, while we use a untransformed strain. Therefore we do not have the same 
reference, but as none of them contain the insert, this would not be the main reason for the 
different results. The mutation frequency for the WT/’vector only’ is 0,7x10-6 mutations/million 
cells, and approximately 1 x10-6 in our WT strain.  
 
Gellon et al. obtain a high mutation frequency for WT/Ntg2, compared to the WT/’vector only’ 
approximately 4 fold higher. By this result they illustrate that overproduction of Ntg2 may 
inactivate the MMR system. Nevertheless mutation frequency measured in the WT/Ntg2 cells 
is not nearly as high as the frequency of the MLH1- cells, which indicate that MLH1 is still 
functioning. However Ntg2 may not bind all of the MLH1 present in the cells. As seen in 
figure 10 we were not able to repeat this result from Gellon et al. as the mutation frequencies 
from the untransformed and transformed cells are nearly the same in our results. As 
expected the mutation frequency in the MLH1- strain, have the highest mutation frequency 
number, as the MMR system have an abolished MMR system due to the deficient MLH1.  
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The mutation frequency for the MLH1-/Ntg2 versus the MLH1-/’vector only’ is not increased 
significant as the Ntg2 does not have MLH1 to bind to. The results of the MLH1- strain by 
Gellon et al. are notably higher than ours, as the MLH1-/’vector only’ is 1,6 fold higher than 
the MLH1- untransformed strain. In general it seems that the cell line used by Gellon et al. 
have a higher mutation frequency, as seen in figure 10.  
 
In total the results from our experiments do not support the data from Gellon et al., 2002 
regarding the effect of Ntg2 on MMR. To examine the cause of our results it would be 
interesting to check if the Ntg2 gene is in fact expressed in the cells. The similarities in most 
of the results between cells with and without Ntg2 lead us to think that the gene might not be 
expressed in excess as expected. In the study from Gellon et al. Ntg2 was fused with Gal4p, 
which make the expression of the gene detectable.  
7.1.1 Discussion of the Mutation Frequency Assay 
It might not be only the different cell lines used, that is the reason for the lack of 
correspondence between Gellon et al’s results and ours. The assay used in this study is only 
part of the experimental procedure used by Gellon et al. They present the assay as one that 
is not especially chosen because of its ability to detect MMR-defects like the other assays in 
the study [Gellon et al., 2002]. In this light, it is central to discuss the assay in our study.  
 
The results from the untransformed cells may indicate that the canavanine resistance assay 
is useably to measure the MMR activity. These results indicate that the CAN1 gene, can be 
used as a measure for the MMR activity. For the EXO1- strains, the elevated mutation 
frequency measured in the assay may not only be due to the lack of exonuclease activity in 
the MMR-system. EXO1 is involved in many other processes regarding maintenance of the 
DNA, for example recombination repair. Therefore the canavanine resistance assay may be 
most relevant to use in cases of major abolishing of the MMR system.  As only a small part of 
the mutations detected, may be caused by other factors than lack of mismatch repair in these 
cases.  
 
Furthermore Qiu et al., 1999 notes that the arginine permease CAN1 is not especially 
sensitive to point mutations such as transversions. As mentioned, the MMR system repairs 
point mutations and IDL’s up to 16 bp long. Therefore it is only some of the mutations 
repaired by MMR system that have an effect on the CAN1 gene, namely the IDL’s causing 
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frameshift-mutations in the gene. As this study investigates the effect of a hypothetic 
abolishing of MLH1 on the MMR, it is not important which mutations are sensitive to CAN1, 
because the MLH1 protein is not involved in mutation-detection. However, it is important if 
only some of the mutations repaired by MMR are detected in the assay.  
 
If the assay does not specific detect MMR defects of weak mutator phenotypes, the 
mutations it does detect might not be caused by an abolished MMR system. If this is the 
case for the results of Gellon et al. as well as for ours, there might be a lot of different 
explanations to the divergent results. Nevertheless Gellon et al. use the canavanine 
resistance assay as well as other assays and observes the same tendency in all assays. 
This may indicate that the canavanine resistance assay can be used to measure the MMR 
activity in this case after all.  
7.2 Perspectives of Ntg2 caused Mutation Frequency and MLH1 Binding  
As a consequence of the discussion in the previous section it is relevant to consider if Gellon 
et al.’s results, regarding mutation frequencies, could be caused by something not depending 
on the binding between Ntg2 and MLH1.  
 
An alternative explanation for the mutation frequencies measured by Gellon et al. can be that 
overexpression of Ntg2 has a mutation causing effect on the cells independent of the MMR 
system. It has been shown that inactivating of Ntg2 can down-regulate the mutagenesis and 
lethality in S. cerevisiae under certain conditions [Guillet and Boiteux, 2002; Boiteux and 
Guillet, 2006; Melo et al., 2004] and Guillet and Boiteux, 2002 (who are co-writers on the 
Gellon et al. study) has proposed a model for Ntg2 caused double-strand breaks and lethality 
in the absence of certain repair proteins. Therefore it might be proposed that the mutation 
frequency measured by Gellon et al., 2002 is caused by a mutagenic action of 
overexpressed Ntg2. 
 
However this does not explain why our study does not show the same mutation frequency as 
Gellon et al., 2002 as we also overexpress Ntg2. Furthermore Gellon et al. does not detect a 
significant elevated mutation frequency when the Ntg2 gene without the proposed MLH1 
binding domain is expressed. In this respect result from another assay is consistent with the 
ones from the canavanine resistance assay. Therefore the hypothesis proposed by Gellon et 
al. explaining their results seems to be valid.  
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This leads us to the question of why Ntg2 might bind MLH1. Gellon et al., 2002 proposes that 
MLH1 is a major regulator of the MMR pathway in the cells and therefore it is important that 
this protein is not expressed in excess. Gellon et al. might indicate that Ntg2 could function 
as a regulator of MLH1, by binding protein in excess. In this respect, it is interesting that the 
concentration of Ntg2-protein, as mentioned, is continuously expressed in the cells. We 
cannot compare the binding of Ntg2 and MLH1 with binding between hMSH2 and hMYH as 
the hypothesis regarding this latter binding seems to be much more developed as reviewed 
in chapter 4.  
 
Even though no direct homologue for the Ntg2 gene of S. cerevisiae has been found in 
humans, hNTH1 has been called the functional human homologue of hNtg2 [Gellon et al., 
2002]. Another human DNA glycosylase MED1 might have some homology to Ntg2 as it 
contains a hMLH1 binding domain and binds hMLH1 in human cells [Gellon et al., 2002; Fan 
& Wilson, 2005]. The reason for this binding in humans might correspond with the reason for 
Ntg2-MLH1 binding in S. cerevisiae. More experiments will have to be conducted though, to 
be able to make this comparison. 
 
Activating and inactivating of proteins by other proteins is widely used in the cells to regulate 
the function of specific proteins/enzymes. If MLH1 is activated or inactivated by other 
proteins this opens a set of possibilities in the case of mutations. If one of the regulative 
proteins is mutated or overexpressed one might expect a phenotypic reaction equal to the 
reaction to a mutation in MMR genes. This proposes a role for Ntg2 in cancer-development. 
If Ntg2 or a human homologue is overexpressed it might cause cancer and the glycosylase 
would be accounted as a proto-oncogene. Once again this is an excessive hypothesis and 
many more experiments will have to be conducted in order to prove it. An experiment that 
would be interesting to conduct is a binding-affinity assay, to determine which of the partners 
of MLH1 and hMLH1 has the greatest affinity. Even though MLH1 might have more than one 
bindingsite for different partners it is interesting as a very weak affinity of Ntg2 might reject 
the hypothesis about the role of Ntg2 in cancer. 
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7.3 Discussion of  Sequencing of Ntg2-insert in pYX213 
As seen in the results from the mutation frequency assay the results in regards of the 
overexpression of Ntg2 is bizarre. If the Ntg2 is not expressed properly, it could be due to 
mutations in the insert in pYX213. The results of the sequencing of this insert however, 
revealed that the gene is in fact a correct copy of the Ntg2-gene without any mutations. 
Therefore, the hypothesis of un-expressed Ntg2 can only be true if there is a problem with 
the promoter region of the gene or problems with the initiation of the transcription. We know 
that the uracil gene on the plasmid does work else-why the cells would not be able to grow in 
the ura- media. Because of this, we know that genes from the plasmid can be transcribed 
and the plasmid itself is not problematic to use in combination with our cell line.    
7.4 Discussion of Sequencing of hEXO1-inserts in pYES2 
As described, it was shown in previous experiments that neither phEXO1 nor two phEXO1 
mutants could complement the MMR-system in S. Cerevisiae BY4741. By sequencing the 
inserts used in the vectors carrying hEXO1 and hEXO1(L410R), hEXO1(T439M), we wanted 
to validate the findings regarding complementation. 
We found that the WT hEXO1 was not mutated or displaced in any way, which indicate that 
the results regarding complementation in S. cerevisiae was not caused by a mutated 
hEXO1.hEXO1(T439M) did not contain other mutations than the one on amino acid number 
439, which support the conclusion regarding the complementation-results also in this case.  
 
hEXO1(L410R) however, contained a 65 bp long insert not found in WT hEXO1. The DNA-
piece started a couple of DNA-bases after the L410R mutation, which was introduced as 
expected. The insert contains a stopcodon in the given readingframe and the protein 
becomes a nonsense-protein. These finding gives no indications on whether the 
hEXO1(L410R)-protein can complement ScMMR, but this is not expectable however, as the 
WT hEXO1 has not been shown to complement. The result is an important finding as this 
plasmid was to be used in other experiments. A new hEXO1(L410R)-plasmid will have to be 
constructed and sequenced. The insertion-mutation in the gene is a repetition of the primer 
used to introduce the (L410R)-mutation. The new-synthesized strand may have looped 
during the polymerisation of the strand, so that a patch of strand is synthesized more that 
one time. The looping most have occurred after the introduction of the (L410R)-mutation, as 
this is also repeated.     
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8 Conclusion 
Overall, it is not possible to conclude anything about the effect of over expression of Ntg2 on 
the mismatch repair system of S. cerevisiae based on the mutation frequency assay. No 
significant differences are observed between the untransformed and Ntg2 transformed cells 
for the WT and EXO1- strains and the results from the MLH1-/pNtg2 strains cannot be 
regarded as correct results. They might be caused by an error in the experimental procedure.  
The error is not to be found in the Ntg2-insert of pYX213 as the sequencing of this insert 
revealed a correct translated Ntg2 protein.  
The sequencing of WT hEXO1, hEXO1(T439M) and hEXO1(L410R) inserts in pYES2 
revealed that the WT hEXO1 and hEXO1(T439M) inserts has the expected DNA-sequence 
and translates to the correct protein. This indicate that mutations in the inserts cannot be the 
reason for the complementation results. The hEXO1(L410R) insert however, contains a 65 
basepair long insertion-mutation not found in wild type hEXO1. The mutation causes the 
gene to translate to a nonsense-protein. The protein is abolished and therefore cannot 
complement the ScMMR. However, it properly wouldn’t complement without the insertion 
mutation, as the WT doesn’t complement.  
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11 Abbreviations 
AP site  apurinic/apyrimidinic site 
BER  Base Excision Repair 
Dam  DNA adenine methylase 
DSB  Double Stranded Break 
dsDNA  Double-stranded DNA 
E. coli  Escherichia coli 
EXO1  Exonuclease I 
Fpg  Formamidopyrimidine DNA glycosylase 
GO  8-oxodG 
hMYH  MutY homolog 
HNPCC  Hereditary Non-Polyposis Colon Cancer 
IDLs  Insertion/deletion loops 
MLH1⋅MLH3 MutL homolog complex 
MLH1⋅PMS2 MutL homolog complex  
MMR  Mismatch Repair 
MSH2⋅MSH3 MutS homolog complex 
MSH2⋅MSH6 MutS homolog complex 
MSI  Microsatellite Instability 
NER  Nucleotide Excision Repair 
PCNA  Proliferating Cell Nuclear Antigen 
PMS2  Post Meiotic Segregation 2 
Pol δ  Ploymerase δ 
bp  Base pair 
RPA  Replication Protein A 
S. cerevisiae Saccharomyces cerevisiae 
SSB  Single-strand binding protein 
XP  Xeroderma pigmentosum 
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12 Appendixes 
12.1 Protocols 
The following sections will describe all the different protocols used during the project period.  
12.1.1 Protocol for Transformation of Yeast Cells 
12.1.1.1 Competent cells 
• Several colonies are inoculated in 50ml YPD medium at 30°C with shaking over night. 
The overnight culture have an OD600 > 1,5. 
• The overnight culture are diluted into 300ml YPD medium to obtain an OD600 = 0,2-
0,3. Cells are then incubated for three hours at 30°C with shaking. 
• The cells are centrifuged for five minutes at 3200 rpm at room temperature, and the 
supernatant is discarded. The cell pellet is resuspended (vortex) in 25ml sterile H2O. 
• The cells are centrifuged for five minutes at 3200 rpm at room temperature and the 
supernatant is removed and placed on ice. The cell pellet is resuspended in 1,5ml 
sterile 1 x TE/LiAc. 
• The competent cells are ready to be used for the transformation. 
12.1.1.2 Transformation 
• 0,1μg vector construct and 0,1μg DNA carrier are added to each tube. 
• 100μl competent cells are added to the tubes and mixed well.  
• 600μl sterile 1 x PEG/LiAc is added to the tubes, mixed well (vortex) and the tubes 
are incubated for 30 minutes at 30°C with shaking.  
• 70μl DMSO (to 10%) are added, mixed by inversion and heat shocked at 42°C in 
water bath for 15 minutes (swirl occasionally). 
• The cells are then chilled on ice and centrifuged 10 seconds at 1000 x G. 
• The supernatant is removed and pellet is resuspended in 0,5ml 1 x TE buffer. 
• 100μl is plated on each plate and incubated at 30°C until colonies appear. 
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12.1.2 Protocol for Mutation Frequency Assay in Yeast 
• Five colonies of each strain are inoculated in 5 ml of an appropriate growth media 
(YPD is used for non transformed, for transformed cells containing pYES2 SD/-ura is 
used and for the transformed cells containing Ntg2 SD/-ura/-arg and SG/-ura/-arg is 
used).  
• The cells are incubated at 30°C with shaking over night. 
• 5 ml media is added to each tube, and OD600 is measured.  
• Media is then added until OD600 is ∼0,15. 
• The cells are the incubated at 30°C with shaking until OD600 is 0,4-0,5, and then 
placed on ice to stop the growth. 
• When the cells have obtained the right OD600, dilution rows are made before plating 
on YPD plates. 
• For plating on the canavanin plates, an amount of the cultures are spin down. The 
aim is to get approximately 10-100 cells pr. plate.  
• The supernatant is poured (about 0,5 ml is left for resuspending) and everything is 
plated on three plats.  
• Plats are incubated at 30°C, and the colonies on the YPD plates are counted after 
three days and the canavanin colonies after seven to ten days. 
12.1.3 Protocol for Sequence Reaction 
• Template DNA 250-500 ng 
Primer (1,6 μM)     1 μl 
Sequencing mix     4 μl 
H2O (add up to)   10 μl 
 
PCR programme (96°C 10 sec. + 50°C 5 sec. + 60°C 4 min.) x 25 + 4°C ∞. 
 
Precipitation of the reaction 
• Add 40 μl of 75%isopropanol and keep at room temperature for minimum 15 minutes 
and maximum 24 hours. 
• Centrifuge at 20.000 x g for 30 minutes at 4°C. 
• Decant supernatant and add 200 μl 75% isopropanol. 
• Centrifuge at 20.000 x g for 15 minutes at 4°C. 
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• Decant supernatant and dry pellet at 90°C with open cap. 
• Pellet is resuspended in 15 μl Hi-Di formamide. 
• Denaturate for 5 minutes at 95°C. 
• Cool down on ice and transfer the content to ABI-prism tubes. 
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12.2 Amino acid sequence of human Exonuclease 1, isoform b aligned with 
wild type hExo1-insert, hExo1(T439M)-insert and hExo1(L410R)-insert 
of the pYES2-plasmid. 
Exonuclease 1, isoform b [Homo sapiens]: A 
 
Wild type hExo1-insert in pYES2: B 
hExo1(T439M)-insert in pYES2: C 
hExo1(L410R)-insert in pYES2: D 
 
A  1    MGIQGLLQFIKEASEPIHVRKYKGQVVAVDTYCWLHKGAIACAEKLAKGEPTDRYVGFCM  60 
B  1    MGIQGLLQFIKEASEPIHVRKYKGQVVAVDTYCWLHKGAIACAEKLAKGEPTDRYVGFCM  60 
C  1    MGIQGLLQFIKEASEPIHVRKYKGQVVAVDTYCWLHKGAIACAEKLAKGEPTDRYVGFCM  60 
D  1    MGIQGLLQFIKEASEPIHVRKYKGQVVAVDTYCWLHKGAIACAEKLAKGEPTDRYVGFCM  60 
 
A  61   KFVNMLLSHGIKPILVFDGCTLPSKKEVERSRRERRQANLLKGKQLLREGKVSEARECFT  120 
B  61   KFVNMLLSHGIKPILVFDGCTLPSKKEVERSRRERRQANLLKGKQLLREGKVSEARECFT  120 
C  61   KFVNMLLSHGIKPILVFDGCTLPSKKEVERSRRERRQANLLKGKQLLREGKVSEARECFT  120 
D  61   KFVNMLLSHGIKPILVFDGCTLPSKKEVERSRRERRQANLLKGKQLLREGKVSEARECFT  120 
 
A  121  RSINITHAMAHKVIKAARSQGVDCLVAPYEADAQLAYLNKAGIVQAIITEDSDLLAFGCK  180 
B  121  RSINITHAMAHKVIKAARSQGVDCLVAPYEADAQLAYLNKAGIVQAIITEDSDLLAFGCK  180 
C  121  RSINITHAMAHKVIKAARSQGVDCLVAPYEADAQLAYLNKAGIVQAIITEDSDLLAFGCK  180 
D  121  RSINITHAMAHKVIKAARSQGVDCLVAPYEADAQLAYLNKAGIVQAIITEDSDLLAFGCK  180 
 
A  181  KVILKMDQFGNGLEIDQARLGMCRQLGDVFTEEKFRYMCILSGCDYLSSLRGIGLAKACK  240 
B  181  KVILKMDQFGNGLEIDQARLGMCRQLGDVFTEEKFRYMCILSGCDYLSSLRGIGLAKACK  240 
C  181  KVILKMDQFGNGLEIDQARLGMCRQLGDVFTEEKFRYMCILSGCDYLSSLRGIGLAKACK  240 
D  181  KVILKMDQFGNGLEIDQARLGMCRQLGDVFTEEKFRYMCILSGCDYLSSLRGIGLAKACK  240 
 
A  241  VLRLANNPDIVKVIKKIGHYLKMNITVPEDYINGFIRANNTFLYQLVFDPIKRKLIPLNA  300 
B  241  VLRLANNPDIVKVIKKIGHYLKMNITVPEDYINGFIRANNTFLYQLVFDPIKRKLIPLNA  300 
C  241  VLRLANNPDIVKVIKKIGHYLKMNITVPEDYINGFIRANNTFLYQLVFDPIKRKLIPLNA  300 
D  241  VLRLANNPDIVKVIKKIGHYLKMNITVPEDYINGFIRANNTFLYQLVFDPIKRKLIPLNA  300 
 
A  301  YEDDVDPETLSYAGQYVDDSIALQIALGNKDINTFEQIDDYNPDTAMPAHSRSHSWDDKT  360 
B  301  YEDDVDPETLSYAGQYVDDSIALQIALGNKDINTFEQIDDYNPDTAMPAHSRSRSWDDKT  360 
C  301  YEDDVDPETLSYAGQYVDDSIALQIALGNKDINTFEQIDDYNPDTAMPAHSRSRSWDDKT  360 
D  301  YEDDVDPETLSYAGQYVDDSIALQIALGNKDINTFEQIDDYNPDTAMPAHSRSRSWDDKT  360 
 
A  361  CQKSANVSSIWHRNYSPRPESGTVSDAPQLKENPSTVGVERVISTKGLNLPRKSSIVKRP  420 
B  361  CQKSANVSSIWHRNYSPRPESGTVSDAPQLKENPSTVGVERVISTKGLNLPRKSSIVKRP  420 
C  361  CQKSANVSSIWHRNYSPRPESGTVSDAPQLKENPSTVGVERVISTKGLNLPRKSSIVKRP  420 
D  361  CQKSANVSSIWHRNYSPRPESGTVSDAPQLKENPSTVGVERVISTKGLNRPRKSSTKGLN  420 
 
A  421  RSAELSEDDLLSQYSLSFTKKTKKNSSEGNKSLSFSEVFVPDLVNGPTNKKSVSTPPRTR  480 
B  421  RSAELSEDDLLSQYSLSFTKKTKKNSSEGNKSLSFSEVFVPDLVNGPTNKKSVSTPPRTR  480 
C  421  RSAELSEDDLLSQYSLSFMKKTKKNSSEGNKSLSFSEVFVPDLVNGPTNKKSVSTPPRTR  480 
D  421  RPRKSSLKG  429 
 
A  481  NKFATFLQRKNEESGAVVVPGTRSRFFCSSDSTDCVSNKVSIQPLDETAVTDKENNLHES  540 
B  481  NKFATFLQRKNEESGAVVVPGTRSRFFCSSDSTDCVSNKVSIQPLDETAVTDKENNLHES  540 
C  481  NKFATFLQRKNEESGAVVVPGTRSRFFCSSDSTDCVSNKVSIQPLDETAVTDKENNLHES  540 
 
A  541  EYGDQEGKRLVDTDVARNSSDDIPNNHIPGDHIPDKATVFTDEESYSFESSKFTRTISPP  600 
B  541  EYGDQEGKRLVDTDVARNSSDDIPNNHIPGDHIPDKATVFTDEESYSFKSSKFTRTISPP  600 
C  541  EYGDQEGKRLVDTDVARNSSDDIPNNHIPGDHIPDKATVFTDEESYSFKSSKFTRTISPP  600 
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A  601  TLGTLRSCFSWSGGLGDFSRTPSPSPSTALQQFRRKSDSPTSLPENNMSDVSQLKSEESS  660 
B  601  TLGTLRSCFSWSGGLGDFSRTPSPSPSTALQQFRRKSDSPTSLPENNMSDVSQLKSEESS  660 
C  601  TLGTLRSCFSWSGGLGDFSRTPSPSPSTALQQFRRKSDSPTSLPENNMSDVSQLKSEESS  660 
 
A  661  DDESHPLREGACSSQSQESGEFSLQSSNASKLSQCSSKDSDSEESDCNIKLLDSQSDQTS  720 
B  661  DDESHPLREGACSSQSQESGEFSLQSSNASKLSQCSSKDSDSEESDCNIKLLDSQSDQTS  720 
C  661  DDESHPLREGACSSQSQESGEFSLQSSNASKLSQCSSKDSDSEESDCNIKLLDSQSDQTS  720 
 
A  721  KLCLSHFSKKDTPLRNKVPGLYKSSSADSLSTTKIKPLGPARASGLSKKPASIQKRKHHN  780 
B  721  KLCLSHFSKKDTPLRNKVPGLYKSSSADSLSTTKIKPLGPARASGLSKKPASIQKRKHHN  780 
C  721  KLCLSHFSKKDTPLRNKVPGLYKSSSADSLSTTKIKPLGPARASGLSKKPASIQKRKHHN  780 
 
A  781  AENKPGLQIKLNELWKNFGFKKDSEKLPPCKKPLSPVRDNIQLTPEAEEDIFNKPECGRV  840 
B  781  AENKPGLQIKLNELWKNFGFKKDSEKLPPCKKPLSPVRDNIQLTPEAEEDIFNKPECGRV  840 
C  781  AENKPGLQIKLNELWKNFGFKKDSEKLPPCKKPLSPVRDNIQLTPEAEEDIFNKPECGRV  840 
 
A  841  QRAIFQ  846 
B  841  QRAIFQ  846 
C  841  QRAIFQ  846 
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12.3 DNA-sequence of the Ntg2-insert of the pYX213-plasmid aligned with 
the Ntg2-gene from Chromosome XV in S.cerevisiae. 
A: Ntg2-insert in pYX213 
B: Ntg2 from S. cerevisiae chromosome XV 
 
A  1       ATGAGAGAGGAAAGTAGGTCTAGGAAGAGAAAGCATATTCCTGTTGATATTGAAGAGGTA  60 
B  249533  ATGAGAGAGGAAAGTAGGTCTAGGAAGAGAAAGCATATTCCTGTTGATATTGAAGAGGTA  249474 
 
A  61      GAAGTTCGATCTAAGTATTTCAAAAAGAATGAGAGAACTGTTGAGTTAGTAAAAGAAAAT  120 
B  249473  GAAGTTCGATCTAAGTATTTCAAAAAGAATGAGAGAACTGTTGAGTTAGTAAAAGAAAAT  249414 
 
A  121     AAAATCAATAAAGATTTGCAAAATTACGGCGGAGTAAATATTGACTGGATCAAGGCACTG  180 
B  249413  AAAATCAATAAAGATTTGCAAAATTACGGCGGAGTAAATATTGACTGGATCAAGGCACTG  249354 
 
A  181     AAGCCAATAGAGTATTTTGAATGGATCGAATCAAGGACTTGTGATGATCCGAGAACTTGG  240 
B  249353  AAGCCAATAGAGTATTTTGAATGGATCGAATCAAGGACTTGTGATGATCCGAGAACTTGG  249294 
 
A  241     GGACGGCCAATAACTAAAGAAGAAATGATTAACGATTCTGGGGCGAAAGTTCCTGAGAGT  300 
B  249293  GGACGGCCAATAACTAAAGAAGAAATGATTAACGATTCTGGGGCGAAAGTTCCTGAGAGT  249234 
 
A  301     TTCTTACCCATATATAATCGGGTGAGATTAATGAGGTCCAAGGTTAAAACCCCGGTAGAT  360 
B  249233  TTCTTACCCATATATAATCGGGTGAGATTAATGAGGTCCAAGGTTAAAACCCCGGTAGAT  249174 
 
A  361     GCTATGGGATGTAGCATGATTCCTGTTTTAGTTTCTAATAAATGTGGGATACCTAGTGAA  420 
B  249173  GCTATGGGATGTAGCATGATTCCTGTTTTAGTTTCTAATAAATGTGGGATACCTAGTGAA  249114 
 
A  421     AAAGTCGATCCAAAGAATTTCAGGCTTCAATTTCTCATTGGCACTATGCTTTCTGCTCAA  480 
B  249113  AAAGTCGATCCAAAGAATTTCAGGCTTCAATTTCTTATTGGCACTATGCTTTCTGCTCAA  249054 
 
A  481     ACGAGGGACGAAAGGATGGCGCAAGCGGCTTTGAATATCACCGAATACTGCTTAAACACA  540 
B  249053  ACGAGGGACGAAAGGATGGCGCAAGCGGCTTTGAATATCACCGAATACTGCTTAAACACA  248994 
 
A  541     TTAAAAATAGCAGAGGGTATTACGCTAGATGGACTGCTTAAAATTGATGAACCTGTATTA  600 
B  248993  TTAAAAATAGCAGAGGGTATTACGCTAGATGGACTGCTTAAAATTGATGAACCTGTATTA  248934 
 
A  601     GCAAATCTAATTCGATGCGTTAGCTTCTATACCAGAAAAGCCAATTTCATCAAAAGAACC  660 
B  248933  GCAAATCTAATTCGATGCGTTAGCTTCTATACCAGAAAAGCCAATTTCATCAAAAGAACC  248874 
 
A  661     GCACAATTATTGGTAGACAATTTCGATTCAGATATACCGTATGATATAGAGGGAATTCTC  720 
B  248873  GCACAATTATTGGTAGACAATTTCGATTCAGATATACCGTATGATATAGAGGGAATTCTC  248814 
 
A  721     TCGTTACCTGGAGTTGGACCTAAAATGGGATATTTAACACTGCAAAAAGGTTGGGGGCTG  780 
B  248813  TCGTTACCTGGAGTTGGACCTAAAATGGGATATTTAACACTGCAAAAAGGTTGGGGGCTG  248754 
 
A  781     ATTGCCGGCATATGCGTCGATGTTCATGTCCATAGGCTGTGTAAAATGTGGAATTGGGTA  840 
B  248753  ATTGCCGGCATATGCGTCGATGTTCATGTCCATAGGCTGTGTAAAATGTGGAATTGGGTA  248694 
 
A  841     GACCCTATTAAGTGTAAGACTGCCGAGCATACTAGAAAGGAGTTACAGGTTTGGCTACCT  900 
B  248693  GACCCTATTAAGTGTAAGACTGCCGAGCATACTAGAAAGGAGTTACAGGTTTGGCTACCT  248634 
 
A  901     CACTCACTGTGGTACGAAATAAACACCGTTTTGGTTGGATTTGGTCAATTGATCTGCATG  960 
B  248633  CACTCACTGTGGTACGAAATAAACACCGTTTTGGTTGGATTTGGTCAATTGATCTGCATG  248574 
 
A  961     GCCAGGGGTAAGAGGTGTGATTTATGTCTAGCAAACGATGTCTGCAATGCTCGCAATGAG  1020 
B  248573  GCCAGGGGTAAGAGGTGTGATTTATGTCTAGCAAACGATGTCTGCAATGCTCGCAATGAG  248514 
 
A  1021    AAGCTAATCGAATCTTCCAAATTTCATCAATTGGAGGACAAAGAAGACATCGAGAAAGTA  1080 
B  248513  AAGCTAATCGAATCTTCCAAATTTCATCAATTGGAGGACAAAGAAGACATCGAGAAAGTA  248454 
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A  1081    TATTCGCATTGGTTGGACACGGTTACAAATGGAATTACAACAGAAAGACACAAGAAAAAA  1140 
B  248453  TATTCGCATTGGTTGGACACGGTTACAAATGGAATTACAACAGAAAGACACAAGAAAAAA  248394 
 
A  1141    TAG  1143 
B  248393 TAG  248391 
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12.4 Primers used for Sequencing 
Primers for wild type hExo1, hExo1(L410R) and hExo1(T439M) in pYES2: 
 
 
 
 Forward-hEXO1-1157(418) 
 292KR3 
 775KR (rev) 
 
555REV (rev) X 
HEX1-380 5'-GTATGTAGGATTTTGTATGAA-3' 
HEX1-780 5'-CAGTTTGGAAATGGACTTGAA-3' 
Y5-EXO1-2109 5'-CGAAGAAAGAGCGATTCCCCCA-3' 
5'-ATGCCCCACAATTGAAGG-3' 
5'-TGTCATCACTGCGTGGGATTGG-3' 
775KR3 5'-CCTGGGCTATATAAGTCCAG-3' 
5'-CTGGACTTATATAGCCCAGG-3' 
Primers for wild type Ntg2 in pYX213: 
 Primer 147 5'-CGGCGGAGTAAATATTGACT-3' 
Primer 258 REV  5'-TTTAGTTATTGGCCGTCCCC-3'  
Primer 927  5'-CGTTTTGGTTGGATTTGGTC-3'  
Primer 1113 REV 5'-TCCATTTGTAACCGTGTCCA-3' 
Primer 17 5'-GGTCTAGGAAGAGAAAGCAT-3' 
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